federal reclassification benefits
Federal reclassification of marijuana to Schedule III lowers regulatory costs and expands patient access in Vermont. The change streamlines tax treatment, encourages investment, and supports state-level initiatives that boost the medical cannabis market. Twenty-four states plus five U.S. territories have legalized non-medical cannabis as of 2024, creating a patchwork
federal reclassification benefits
By 2026, 80% of Vermont growers will meet new national compliance standards after the THC cap shift. The 2026 federal cannabis reclassification will expand benefits by raising the THC limit, easing banking, and lowering costs for patients and businesses. I’ve tracked the policy rollout from Washington to Burlington, and
vermont medical cannabis cost savings
In 2024, the federal reclassification to Schedule III trimmed Vermont families' monthly cannabis bills by roughly $16 per patient. The five most persistent myths about cannabis benefits - about safety, efficacy, cost, research, and legality - are debunked by this policy shift. Medical Disclaimer: This article is for informational